A PureTech startup banks $180M for a new IPF drug
A PureTech startup banks $180M for a new IPF drug (BioPharma Dive.)
Puretech Health
LON: PRTC ~$300M MCAP
PureTech Health is a clinical-stage biotherapeutics company developing innovative medicines for serious diseases. It founded and spun out multiple companies including Karuna, Gelesis, and Celea, with a current focus on lymphatic and CNS-targeted therapeutics.
Company Info
Sector:Biotherapeutics Holding Company
Headquarters:Boston, Massachusetts, USA
Founded:2005
Website:www.puretechhealth.com/